Nanotechnology-Based Targeted Drug Delivery Systems for Brain Tumors addresses brain anatomy and tumors and the progress and challenges in delivering drugs across the blood brain barrier. Several chapters are devoted to the latest technologies and advances in nanotechnology, along with practical solutions on how to design more effective nanocarriers for drug and gene delivery. This valuable resource prepares readers to develop novel drug delivery systems for the treatment of brain tumors that further promote the latest nanomedical technologies.
- Addresses the progress and challenges inherent in delivering drugs across the blood brain barrier and offers strategies to maximize effectiveness
- Draws upon the experience and expertise of international scientists working in the fields of drug delivery and nanomedicine
- Considers the future possibilities of nanotechnology for delivering nanocarriers that better diagnose and treat brain tumors
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
2. Angiogenesis in brain tumors
3. Physiology of the Blood Brain Barrier (BBB) and mechanisms of Transport across the BBB
4. Active Targeting Systems (Ligands) / Receptor overexpressed on brain
5. Nanotechnology in Brain Targeting
6. Polymeric nanoparticles based drug delivery for brain tumors
7. Solid lipid nanoparticles (SLN)based drug delivery for brain tumors
8. Liposomes based drug delivery for brain tumors
9. Dendrimers based drug delivery for brain tumors
10. Micelles based drug delivery for brain tumors
11. Nanoemulsions based drug delivery for brain tumors
12. Nanogel based drug delivery for brain tumors
13. Beyond the blood-brain barrier
facing new challenges
14. Towards development of neuro-diagnostic nano-imaging platform
15. Future prospects of nanoparticles on brain targeted drug delivery
Dr. Prashant Kesharwani is currently working as Assistant Professor, Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India. He received his doctoral degree in Pharmaceutical Sciences from the Dr H.S. Gour University (Sagar, India) with Prof N.K Jain's group. He is a recipient of several internationally acclaimed awards viz "Ramanujan Fellowship, DST, India-2017, "Excellence Research Award-2014, "Young Innovator Award (Gold medal)-2012, "International Travel Award/Grant from DST (New Delhi), and INSA (CCSTDS, Chennai)-2012. He has received ICMR Senior Research Fellowship (in PhD) and AICTE Junior Research Fellowship (in M. Pharm.). After his doctorate, he worked as postdoctoral fellows in the Wayne State University, Detroit (Michigan, USA). Dr. Kesharwani subsequently joined the School of Pharmacy, International Medical University (Malaysia) as lecturer in Pharmaceutical Technology. Subsequently he joined Central Drug Research Institute (CDRI), Lucknow as Ramanujan Fellow. An overarching goal of his current research is the development of nano-engineered drug delivery systems for cancer through with prime focus on dendrimer and polymeric nanomicelles mediated drug delivery systems. Dr. Kesharwani is a co-author on more than 120 publications in high impact factor international journals and 4 international books with total citations of more than 3300 (h index is 27 and i-10 index is 65 as per Google Scholar).
Dr. Umesh Gupta, currently working as Assistant Professor at Department of Pharmacy, Central University of Rajasthan, India, did his bachelor's, master's and doctorate degree in Pharmaceutical Sciences from Dr. H. S. Gour University, India under the mentorship of Prof. NK Jain. He has recently been awarded for "DAAD Research Stays for Academics and Scientists at Leibniz-institut fur Polymerforschung Dresden, Germany. He has the past experience of Research Scientist at Ranbaxy Research Laboratories, India and Post-Doctoral Research Associate at South Dakota State University, USA. HE is also recipient of Young Scientist Award by Department of Science and Technology, Government of India as well as Ranbaxy Science Scholar Award 2008 by Ranbaxy Research Laboratories, India. He has been awarded more than 3-4 times the overseas travel award by different funding agencies of Indian government to share and present his research at international platform in countries like Germany, USA and Singapore etc. He has more than ten years of research and academic experience. The area of research is mainly focused on dendrimer mediated drug delivery, solubilization and targeting. His laboratory equally focuses on effective brain delivery through nanotechnological carriers such as polymeric micelles, nanoparticles and dendrimers. He has more than 48 publications and seven book chapters to his credit with total citations of more than 2300 (h index of 23 as per Google Scholar).